BTT+CAP Slaughter Flashcards

0
Q

Survival?

A

180d = 91%

360d = 84%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

N=?

Primary Outcome?

A

N=332. (140+192)

Success=Survival on orig. device, transplant or explant for recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Conclusion ?

A

HVAD as BTT demonstrates high 180d survival rate despite low transplant rate.
AE’s are similar or better than historical BTT trials, despite longer exposure times due to longer survival & lower transplant rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Follow up ?

A

At least 6 mos. to

Over 3 years

Analysis July 31, 2012

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Driveline Infection

A
  1. 9% 56/332

0. 25 PPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Bleeding

A

Req. Surgery 14.8% 49/332
0.19 PPY

GI Bleeding 12.7% 42/332
0.28 PPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stroke Overall

A
  1. 8% (2pts having both)

28. 6% of stroke events fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ICVA

A
  1. 5% 25/332
  2. 09 PPY

88% survived event

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HCVA

A
  1. 8% 26/332
  2. 09 PPY

46% of HCVA’s fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hemolysis

A
  1. 2% 4/332

0. 02 PPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Thrombus

Device Exchange

A

4.2%

  1. 7%
    - 2.1% proc. related
    - 4.2% suspected thrombus
    - 2.4% other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

After March 15, 2011 Pump Exchange for Thrombus

A

0.063 PPY to 0.027 PPY

55% drop

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

After March 15, 2011 Strokes

A

ICVA w/ MRS>0
5.1% to 2.8% (45% drop)

0.089 PPY to 0.047 PPY

HCVA’s w/MRS >0
5.1% to 4.7% (8% drop)

0.082 PPY to 0.074 PPY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

6MWT distance improvement

A

Distance tripled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Study duration

A

3 yrs. 4 mos

August 2008 - December 2011

Medical Therapy & Device Design Enhancements March 2011 - December 2011

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Medical Therapy & Device Design Enhancements

A

New Coring Tool
Sintered Pump
ASA 325mg
INR 2.0 - 3.0

16
Q

Stroke Rate compared to HMII BTT & CAP trials

A

HMII Miller (BTT)
ICVA 0.13 PPY vs 0.09 HVAD
HCVA 0.05 PPY vs 0.09 HVAD

HMII Pagani (CAP)
ICVA 0.09 PPY vs 0.09 HVAD
HCVA 0.05 PPY vs 0.09 HVAD

17
Q

ReVolve EU Study Stroke in PPY?

A

0.08 PPY

17
Q

ReVolve EU Study Stroke in PPY?

A

0.08 PPY

18
Q

Freedom from pump thrombus

A

98% at 3 mos.
92% at 1 yr.

Freedom from exchange for thrombus
99% at 3 mos.
95% at 1 yr.

20
Q

HVAD Exchange for suspected thrombus

A

0.05 PPY (4.2%)

21
Q

HVAD exchange rate for suspected thrombus post Anticoagulation adjustment, coring tool & sintering?

A

0.03 PPY

A 55% drop in exchange rate for suspected thrombus